Metastatic endometrial cancer in lung and liver: complete and prolonged response to hormonal therapy with progestins.
Gynecol Oncol
; 72(2): 250-5, 1999 Feb.
Article
em En
| MEDLINE
| ID: mdl-10021310
ABSTRACT
A double complete and prolonged response of metastatic endometrial carcinoma to medroxyprogesterone is reported. A 61-year-old woman with metastatic endometrial carcinoma in lung and liver achieved a complete clinical response with medroxyprogesterone lasting for 2 years. She discontinued the therapy by herself and developed a pulmonary relapse, which disappeared after retreatment with the same hormonal therapy. At present, she is alive without evidence of disease 6 years after starting progestins for metastatic disease and 14 years after treatment of the primary tumor. Progestin therapy in metastatic endometrial carcinoma is discussed, emphasizing the factors predicting response.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Carcinoma
/
Neoplasias do Endométrio
/
Congêneres da Progesterona
/
Neoplasias Hepáticas
/
Neoplasias Pulmonares
/
Medroxiprogesterona
Tipo de estudo:
Prognostic_studies
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Gynecol Oncol
Ano de publicação:
1999
Tipo de documento:
Article
País de afiliação:
Espanha